Biotech Stocks Hit 52-Week Highs - TOI, IKT, ANRO, ELV, PRVArttnews·Jul 15 at 02:55 AMANRO+7.15%IKT+3.17%
Alto Neuroscience Launches $93.9M Stock Offering at $26.48 in BofA-Led UnderwritingTradingView·Jul 14 at 05:13 AMANRO+7.15%BAC+1.08%
Alto Neuroscience Highlights Strong Cash, Expands ALTO-207 TrialsTip Ranks·Jul 13 at 07:51 AMANRO+7.15%
Alto Neuroscience estimates June 30 cash, equivalents and restricted cash at $244.2 millionPUBT·Jul 13 at 06:40 AMANRO+7.15%
Alto Neuroscience Announces Pricing of $100.0 Million Underwritten Registered Direct Offering of Common Stock | ANRO Stock NewsStockTitan·Jul 12 at 10:47 PMANRO+7.15%
Alto Neuroscience, Inc. Stock 12‑Month Price Target Cut to $34.8, Implies 33% UpsideTradingView·Jul 8 at 11:20 PMANRO+7.15%
Alto Neuroscience Highlights Nature Medicine Publication Demonstrating Significant Effects of Pramipexole on Anhedonia | ANRO Stock NewsStockTitan·Jun 14 at 11:03 PMANRO+7.15%
Alto Neuroscience Reports First Quarter 2026 Financial Results and Recent Business Highlights | ANRO Stock NewsStockTitan·May 12 at 10:05 PMANRO+7.15%FBT+0.87%
